APO Research
Talk to an analyst

APO RESEARCH · REPORT

Colon Targeted Drug Delivery Systems

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Colon Targeted Drug Delivery Systems Market Outlook and Growth Opportunities 2026

2 January 2026193 pages

Choose your research edition.

Industry ResearchColon Targeted Drug Delivery Systems Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Colon Targeted Drug Delivery Systems Industry Growth and Trends Forecast to 203262 pages · $3,450 USDMarket StructureGlobal Colon Targeted Drug Delivery Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Colon Targeted Drug Delivery Systems Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Colon Targeted Drug Delivery Systems Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Colon Targeted Drug Delivery Systems market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Colon Targeted Drug Delivery Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Colon Targeted Drug Delivery Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Colon Targeted Drug Delivery Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Colon Targeted Drug Delivery Systems market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Colon Targeted Drug Delivery Systems market include Lonza Pharma Biotech, Tillotts Pharma (Zeria Group) and Evonik Health Care, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Colon Targeted Drug Delivery Systems market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Colon Targeted Drug Delivery Systems and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Colon Targeted Drug Delivery Systems revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Colon Targeted Drug Delivery Systems market.

Colon Targeted Drug Delivery Systems Segment by Company

Lonza Pharma Biotech

Tillotts Pharma (Zeria Group)

Evonik Health Care

Colon Targeted Drug Delivery Systems Segment by Type

Osmotic Controlled Drug Delivery (ORDS-CT)

Pressure Controlled Drug-Delivery Systems

Others

Colon Targeted Drug Delivery Systems Segment by Application

Hospital

Biology Laboratory

Other

Colon Targeted Drug Delivery Systems Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Colon Targeted Drug Delivery Systems status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Colon Targeted Drug Delivery Systems key companies, revenue, market share, and recent developments.

3. To split the Colon Targeted Drug Delivery Systems breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Colon Targeted Drug Delivery Systems market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Colon Targeted Drug Delivery Systems significant trends, drivers, influence factors in global and regions.

6. To analyze Colon Targeted Drug Delivery Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colon Targeted Drug Delivery Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Colon Targeted Drug Delivery Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colon Targeted Drug Delivery Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Colon Targeted Drug Delivery Systems industry.

Chapter 3: Detailed analysis of Colon Targeted Drug Delivery Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Colon Targeted Drug Delivery Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Colon Targeted Drug Delivery Systems in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Colon Targeted Drug Delivery Systems Industry Trends Table 2. Colon Targeted Drug Delivery Systems Industry Drivers Table 3. Colon Targeted Drug Delivery Systems Industry Opportunities and Challenges Table 4. Colon Targeted Drug Delivery Systems Industry Restraints Table 5. Global Colon Targeted Drug Delivery Systems Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Colon Targeted Drug Delivery Systems Revenue Share by Company (2021-2026) Table 7. Global Colon Targeted Drug Delivery Systems Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Colon Targeted Drug Delivery Systems Key Company Manufacturing Base & Headquarters Table 9. Global Colon Targeted Drug Delivery Systems Company, Product Type & Application Table 10. Global Colon Targeted Drug Delivery Systems Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Colon Targeted Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Osmotic Controlled Drug Delivery (ORDS-CT) Table 15. Significant Companies of Pressure Controlled Drug-Delivery Systems Table 16. Significant Companies of Others Table 17. Global Colon Targeted Drug Delivery Systems Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Colon Targeted Drug Delivery Systems Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Colon Targeted Drug Delivery Systems Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Colon Targeted Drug Delivery Systems Sales Value Share by Type (2021-2026) Table 21. Global Colon Targeted Drug Delivery Systems Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Biology Laboratory Table 24. Significant Companies of Other Table 25. Global Colon Targeted Drug Delivery Systems Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Colon Targeted Drug Delivery Systems Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Colon Targeted Drug Delivery Systems Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Colon Targeted Drug Delivery Systems Sales Value Share by Application (2021-2026) Table 29. Global Colon Targeted Drug Delivery Systems Sales Value Share by Application (2027-2032) Table 30. Global Colon Targeted Drug Delivery Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Colon Targeted Drug Delivery Systems Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Colon Targeted Drug Delivery Systems Sales Value Share by Region (2021-2026) Table 33. Global Colon Targeted Drug Delivery Systems Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Colon Targeted Drug Delivery Systems Sales Value Share by Region (2027-2032) Table 35. Global Colon Targeted Drug Delivery Systems Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Colon Targeted Drug Delivery Systems Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Colon Targeted Drug Delivery Systems Sales Value Market Share by Country (2021-2026) Table 38. Global Colon Targeted Drug Delivery Systems Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Colon Targeted Drug Delivery Systems Sales Value Market Share by Country (2027-2032) Table 40. Lonza Pharma Biotech Company Information Table 41. Lonza Pharma Biotech Business Overview Table 42. Lonza Pharma Biotech Colon Targeted Drug Delivery Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Lonza Pharma Biotech Colon Targeted Drug Delivery Systems Product Portfolio Table 44. Lonza Pharma Biotech Recent Development Table 45. Tillotts Pharma (Zeria Group) Company Information Table 46. Tillotts Pharma (Zeria Group) Business Overview Table 47. Tillotts Pharma (Zeria Group) Colon Targeted Drug Delivery Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Tillotts Pharma (Zeria Group) Colon Targeted Drug Delivery Systems Product Portfolio Table 49. Tillotts Pharma (Zeria Group) Recent Development Table 50. Evonik Health Care Company Information Table 51. Evonik Health Care Business Overview Table 52. Evonik Health Care Colon Targeted Drug Delivery Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Evonik Health Care Colon Targeted Drug Delivery Systems Product Portfolio Table 54. Evonik Health Care Recent Development Table 55. Research Programs/Design for This Report Table 56. Authors List of This Report Table 57. Secondary Sources Table 58. Primary Sources List of Figures Figure 1. Colon Targeted Drug Delivery Systems Product Image Figure 2. Global Colon Targeted Drug Delivery Systems Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Colon Targeted Drug Delivery Systems Market Size (2021-2032) & (US$ Million) Figure 4. Global Colon Targeted Drug Delivery Systems Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Osmotic Controlled Drug Delivery (ORDS-CT) Image Figure 8. Pressure Controlled Drug-Delivery Systems Image Figure 9. Others Image Figure 10. Global Colon Targeted Drug Delivery Systems Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Colon Targeted Drug Delivery Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Colon Targeted Drug Delivery Systems Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Biology Laboratory Image Figure 15. Other Image Figure 16. Global Colon Targeted Drug Delivery Systems Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Colon Targeted Drug Delivery Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Colon Targeted Drug Delivery Systems Sales Value Share by Application (2021-2032) Figure 19. Global Colon Targeted Drug Delivery Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Colon Targeted Drug Delivery Systems Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Colon Targeted Drug Delivery Systems Sales Value (2021-2032) & (US$ Million) Figure 22. North America Colon Targeted Drug Delivery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Colon Targeted Drug Delivery Systems Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Colon Targeted Drug Delivery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Colon Targeted Drug Delivery Systems Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Colon Targeted Drug Delivery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Colon Targeted Drug Delivery Systems Sales Value (2021-2032) & (US$ Million) Figure 28. South America Colon Targeted Drug Delivery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Colon Targeted Drug Delivery Systems Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Colon Targeted Drug Delivery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Osmotic Controlled Drug Delivery (ORDS-CT)
  • Pressure Controlled Drug-Delivery Systems
  • Others
Applications
  • Hospital
  • Biology Laboratory
  • Other
Companies covered
  • Lonza Pharma Biotech
  • Tillotts Pharma (Zeria Group)
  • Evonik Health Care

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Colon Targeted Drug Delivery Systems Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Colon Targeted Drug Delivery Systems Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Colon Targeted Drug Delivery Systems Market Dynamics
  1. 2.1 Colon Targeted Drug Delivery Systems Industry Trends
  2. 2.2 Colon Targeted Drug Delivery Systems Industry Drivers
  3. 2.3 Colon Targeted Drug Delivery Systems Industry Opportunities and Challenges
  4. 2.4 Colon Targeted Drug Delivery Systems Industry Restraints
3 Colon Targeted Drug Delivery Systems Market by Company
  1. 3.1 Global Colon Targeted Drug Delivery Systems Company Revenue Ranking in 2025
  2. 3.2 Global Colon Targeted Drug Delivery Systems Revenue by Company (2021-2026)
  3. 3.3 Global Colon Targeted Drug Delivery Systems Company Ranking (2024-2026)
  4. 3.4 Global Colon Targeted Drug Delivery Systems Company Manufacturing Base and Headquarters
  5. 3.5 Global Colon Targeted Drug Delivery Systems Company Product Type and Application
  6. 3.6 Global Colon Targeted Drug Delivery Systems Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Colon Targeted Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Colon Targeted Drug Delivery Systems Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Colon Targeted Drug Delivery Systems Market by Type
  1. 4.1 Colon Targeted Drug Delivery Systems Type Introduction
  2. 4.1.1 Osmotic Controlled Drug Delivery (ORDS-CT)
  3. 4.1.2 Pressure Controlled Drug-Delivery Systems
  4. 4.1.3 Others
  5. 4.2 Global Colon Targeted Drug Delivery Systems Sales Value by Type
  6. 4.2.1 Global Colon Targeted Drug Delivery Systems Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Colon Targeted Drug Delivery Systems Sales Value by Type (2021-2032)
  8. 4.2.3 Global Colon Targeted Drug Delivery Systems Sales Value Share by Type (2021-2032)
5 Colon Targeted Drug Delivery Systems Market by Application
  1. 5.1 Colon Targeted Drug Delivery Systems Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Biology Laboratory
  4. 5.1.3 Other
  5. 5.2 Global Colon Targeted Drug Delivery Systems Sales Value by Application
  6. 5.2.1 Global Colon Targeted Drug Delivery Systems Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Colon Targeted Drug Delivery Systems Sales Value by Application (2021-2032)
  8. 5.2.3 Global Colon Targeted Drug Delivery Systems Sales Value Share by Application (2021-2032)
6 Colon Targeted Drug Delivery Systems Regional Value Analysis
  1. 6.1 Global Colon Targeted Drug Delivery Systems Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Colon Targeted Drug Delivery Systems Sales Value by Region (2021-2032)
  3. 6.2.1 Global Colon Targeted Drug Delivery Systems Sales Value by Region: 2021-2026
  4. 6.2.2 Global Colon Targeted Drug Delivery Systems Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Colon Targeted Drug Delivery Systems Sales Value (2021-2032)
  7. 6.3.2 North America Colon Targeted Drug Delivery Systems Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Colon Targeted Drug Delivery Systems Sales Value (2021-2032)
  10. 6.4.2 Europe Colon Targeted Drug Delivery Systems Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Colon Targeted Drug Delivery Systems Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Colon Targeted Drug Delivery Systems Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Colon Targeted Drug Delivery Systems Sales Value (2021-2032)
  16. 6.6.2 South America Colon Targeted Drug Delivery Systems Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Colon Targeted Drug Delivery Systems Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Colon Targeted Drug Delivery Systems Sales Value Share by Country, 2025 VS 2032
7 Colon Targeted Drug Delivery Systems Country-level Value Analysis
  1. 7.1 Global Colon Targeted Drug Delivery Systems Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Colon Targeted Drug Delivery Systems Sales Value by Country (2021-2032)
  3. 7.2.1 Global Colon Targeted Drug Delivery Systems Sales Value by Country (2021-2026)
  4. 7.2.2 Global Colon Targeted Drug Delivery Systems Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Colon Targeted Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Colon Targeted Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Colon Targeted Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lonza Pharma Biotech
  2. 8.1.1 Lonza Pharma Biotech Company Information
  3. 8.1.2 Lonza Pharma Biotech Business Overview
  4. 8.1.3 Lonza Pharma Biotech Colon Targeted Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lonza Pharma Biotech Colon Targeted Drug Delivery Systems Product Portfolio
  6. 8.1.5 Lonza Pharma Biotech Recent Developments
  7. 8.2 Tillotts Pharma (Zeria Group)
  8. 8.2.1 Tillotts Pharma (Zeria Group) Company Information
  9. 8.2.2 Tillotts Pharma (Zeria Group) Business Overview
  10. 8.2.3 Tillotts Pharma (Zeria Group) Colon Targeted Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Tillotts Pharma (Zeria Group) Colon Targeted Drug Delivery Systems Product Portfolio
  12. 8.2.5 Tillotts Pharma (Zeria Group) Recent Developments
  13. 8.3 Evonik Health Care
  14. 8.3.1 Evonik Health Care Company Information
  15. 8.3.2 Evonik Health Care Business Overview
  16. 8.3.3 Evonik Health Care Colon Targeted Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Evonik Health Care Colon Targeted Drug Delivery Systems Product Portfolio
  18. 8.3.5 Evonik Health Care Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst